BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 20634190)

  • 1. Intravenous immunoglobulin and idiopathic secondary recurrent miscarriage: a multicentered randomized placebo-controlled trial.
    Stephenson MD; Kutteh WH; Purkiss S; Librach C; Schultz P; Houlihan E; Liao C
    Hum Reprod; 2010 Sep; 25(9):2203-9. PubMed ID: 20634190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention of unexplained recurrent spontaneous abortion using intravenous immunoglobulin: a prospective, randomized, double-blinded, placebo-controlled trial.
    Stephenson MD; Dreher K; Houlihan E; Wu V
    Am J Reprod Immunol; 1998 Feb; 39(2):82-8. PubMed ID: 9506206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravenous immunoglobulin treatment for secondary recurrent miscarriage: a randomised, double-blind, placebo-controlled trial.
    Christiansen OB; Larsen EC; Egerup P; Lunoee L; Egestad L; Nielsen HS
    BJOG; 2015 Mar; 122(4):500-8. PubMed ID: 25412569
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized, double-blind, placebo-controlled trial of intravenous immunoglobulin in the prevention of recurrent miscarriage: evidence for a therapeutic effect in women with secondary recurrent miscarriage.
    Christiansen OB; Pedersen B; Rosgaard A; Husth M
    Hum Reprod; 2002 Mar; 17(3):809-16. PubMed ID: 11870141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recombinant human granulocyte- colony stimulating factor in women with unexplained recurrent pregnancy losses: a randomized clinical trial.
    Eapen A; Joing M; Kwon P; Tong J; Maneta E; De Santo C; Mussai F; Lissauer D; Carter D;
    Hum Reprod; 2019 Mar; 34(3):424-432. PubMed ID: 30776296
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of intravenous immunoglobulin for treatment of recurrent miscarriage: a systematic review.
    Hutton B; Sharma R; Fergusson D; Tinmouth A; Hebert P; Jamieson J; Walker M
    BJOG; 2007 Feb; 114(2):134-42. PubMed ID: 17166218
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravenous immunoglobulin for treatment of recurrent pregnancy loss.
    Coulam CB; Krysa L; Stern JJ; Bustillo M
    Am J Reprod Immunol; 1995 Dec; 34(6):333-7. PubMed ID: 8607936
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A systematic review of intravenous immunoglobulin for treatment of unexplained recurrent miscarriage.
    Ata B; Tan SL; Shehata F; Holzer H; Buckett W
    Fertil Steril; 2011 Mar; 95(3):1080-5.e1-2. PubMed ID: 21232738
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravenous immunoglobulin treatment in women with four or more recurrent pregnancy losses: A double-blind, randomised, placebo-controlled trial.
    Yamada H; Deguchi M; Saito S; Takeshita T; Mitsui M; Saito T; Nagamatsu T; Takakuwa K; Nakatsuka M; Yoneda S; Egashira K; Tachibana M; Matsubara K; Honda R; Fukui A; Tanaka K; Sengoku K; Endo T; Yata H
    EClinicalMedicine; 2022 Aug; 50():101527. PubMed ID: 35795714
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention of recurrent spontaneous abortion by intravenous immunoglobulin: a double-blind placebo-controlled study.
    Jablonowska B; Selbing A; Palfi M; Ernerudh J; Kjellberg S; Lindton B
    Hum Reprod; 1999 Mar; 14(3):838-41. PubMed ID: 10221723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment with intravenous immunoglobulin in patients with recurrent pregnancy loss: An update.
    Christiansen OB; Kolte AM; Krog MC; Nielsen HS; Egerup P
    J Reprod Immunol; 2019 Jun; 133():37-42. PubMed ID: 31238263
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A two-center study on the pharmacokinetics of intravenous immunoglobulin before and during pregnancy in healthy women with poor obstetrical histories.
    Ensom MH; Stephenson MD
    Hum Reprod; 2011 Sep; 26(9):2283-8. PubMed ID: 21771770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravenous immunoglobulin in the prevention of recurrent miscarriage. The German RSA/IVIG Group.
    Br J Obstet Gynaecol; 1994 Dec; 101(12):1072-7. PubMed ID: 7826961
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progesterone to prevent miscarriage in women with early pregnancy bleeding: the PRISM RCT.
    Coomarasamy A; Harb HM; Devall AJ; Cheed V; Roberts TE; Goranitis I; Ogwulu CB; Williams HM; Gallos ID; Eapen A; Daniels JP; Ahmed A; Bender-Atik R; Bhatia K; Bottomley C; Brewin J; Choudhary M; Crosfill F; Deb S; Duncan WC; Ewer A; Hinshaw K; Holland T; Izzat F; Johns J; Lumsden MA; Manda P; Norman JE; Nunes N; Overton CE; Kriedt K; Quenby S; Rao S; Ross J; Shahid A; Underwood M; Vaithilingham N; Watkins L; Wykes C; Horne AW; Jurkovic D; Middleton LJ
    Health Technol Assess; 2020 Jun; 24(33):1-70. PubMed ID: 32609084
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of intravenous immunoglobulin passive immunotherapy on unexplained recurrent spontaneous abortion: a meta-analysis.
    Wang SW; Zhong SY; Lou LJ; Hu ZF; Sun HY; Zhu HY
    Reprod Biomed Online; 2016 Dec; 33(6):720-736. PubMed ID: 27720163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravenous immunoglobulin in the prevention of recurrent miscarriage: does it work?
    Christiansen OB; Nielsen HS
    Chem Immunol Allergy; 2005; 88():117-127. PubMed ID: 16129941
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravenous immunoglobulin use in patients with unexplained recurrent pregnancy loss.
    Banjar S; Kadour E; Khoudja R; Ton-Leclerc S; Beauchamp C; Beltempo M; Dahan MH; Gold P; Jacques Kadoch I; Jamal W; Laskin C; Mahutte N; Reinblatt SL; Sylvestre C; Buckett W; Genest G
    Am J Reprod Immunol; 2023 Aug; 90(2):e13737. PubMed ID: 37491929
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Critical analysis of intravenous immunoglobulin therapy for recurrent miscarriage.
    Daya S; Gunby J; Porter F; Scott J; Clark DA
    Hum Reprod Update; 1999; 5(5):475-82. PubMed ID: 10582784
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Further experience with intravenous immunoglobulin in women with recurrent miscarriage and a poor prognosis.
    Carp HJ; Toder V; Gazit E; Ahiron R; Torchinski A; Mashiach S; Shoenfeld Y
    Am J Reprod Immunol; 2001 Oct; 46(4):268-73. PubMed ID: 11642675
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High doses of intravenous immunoglobulin stimulate regulatory T cell and suppress natural killer cell in women with recurrent pregnancy loss.
    Yamada H; Deguchi M; Saito S; Takeshita T; Mitsui M; Saito T; Nagamatsu T; Takakuwa K; Nakatsuka M; Yoneda S; Egashira K; Tachibana M; Matsubara K; Honda R; Fukui A; Tanaka K; Sengoku K; Endo T; Yata H
    J Reprod Immunol; 2023 Aug; 158():103977. PubMed ID: 37354783
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.